What Chaplains Should Know About Psychedelic Medicines

In this webinar, our guests offered a presentation for chaplains on psychedelic medicines, with a particular focus on psychedelics' potential application for end of life and palliative care (EOLPC) patients. Chaplains served as study clinicians in a recent clinical trial of psilocybin therapy at UCSF, and chaplains are now being included in more trials with EOLPC populations both at Dana-Farber Cancer Institute and Emory Healthcare. This presentation looks toward a future of greater openness to, and recognition of the benefits of, working with chaplains as the field of psychedelic medicine continues to grow.[/vc_column_text][/vc_column][/vc_row . . .

This content is only available to subscribers to the Chaplaincy Innovation Lab at the Innovator level.

Most archived webinars are restricted to users at the Innovator level.

You can explore subscription options right here! You may also login if you already have an account.